Source: BIOPHARMA REPORTER, 3//29/22


While skills shortages present one of the main challenges to the biopharma industry, North Carolina believes its investments in the life science ecosystem have given it a 'multiple decade jumpstart’ in building a successful biopharma hub for both manufacturing and research.

For more of this story, click here.